Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New York Analyst: Eli Lilly’s ImClone Acquisition Carries ‘Promise, Risks’
New York Analyst: Eli Lilly’s ImClone Acquisition Carries ‘Promise, Risks’
New York Analyst: Eli Lilly’s ImClone Acquisition Carries ‘Promise, Risks’
Submitted by
admin
on October 9, 2008 - 12:17pm
Source:
Midwest Business
Headline:
New York Analyst: Eli Lilly’s ImClone Acquisition Carries ‘Promise, Risks’
Do Not Allow Advertisers to Use My Personal information
